athenahealth Inc. (ATHN) Price Target Increased to $110.00 by Analysts at Jefferies Group
athenahealth Inc. (NASDAQ:ATHN) had its price objective lifted by equities research analysts at Jefferies Group to $110.00 in a report released on Friday. Jefferies Group’s target price indicates a potential downside of 12.93% from the company’s previous close.
Several other research firms also recently issued reports on ATHN. Evercore ISI raised shares of athenahealth from a “hold” rating to a “buy” rating and set a $152.00 price target on the stock in a research note on Monday. Morgan Stanley dropped their target price on shares of athenahealth from $186.00 to $153.00 and set an “overweight” rating for the company in a research report on Monday, July 25th. Zacks Investment Research downgraded shares of athenahealth from a “hold” rating to a “sell” rating in a research report on Friday, July 29th. Leerink Swann reissued a “hold” rating on shares of athenahealth in a research report on Thursday, June 16th. Finally, Deutsche Bank AG downgraded shares of athenahealth from a “buy” rating to a “hold” rating and dropped their target price for the stock from $165.00 to $147.00 in a research report on Friday, July 22nd. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and nine have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $149.95.
Shares of athenahealth (NASDAQ:ATHN) traded up 0.16% during trading on Friday, reaching $126.54. The company had a trading volume of 11,971 shares. The stock’s 50-day moving average price is $123.69 and its 200-day moving average price is $129.72. athenahealth has a 52 week low of $114.59 and a 52 week high of $170.42. The company has a market capitalization of $4.98 billion, a PE ratio of 465.22 and a beta of 1.28.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/14/athenahealth-inc-athn-price-target-increased-to-110-00-by-analysts-at-jefferies-group.html
athenahealth (NASDAQ:ATHN) last released its quarterly earnings results on Thursday, July 21st. The company reported $0.34 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.42 by $0.08. athenahealth had a return on equity of 5.16% and a net margin of 1.06%. The firm had revenue of $261.90 million for the quarter, compared to analysts’ expectations of $274.07 million. On average, equities analysts expect that athenahealth will post $1.77 EPS for the current fiscal year.
In related news, Director Brandon H. Hull sold 2,400 shares of the business’s stock in a transaction that occurred on Monday, October 10th. The shares were sold at an average price of $130.00, for a total value of $312,000.00. Following the sale, the director now directly owns 3,987 shares in the company, valued at approximately $518,310. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Bradford Kyle Armbrester sold 2,545 shares of the business’s stock in a transaction that occurred on Monday, October 10th. The stock was sold at an average price of $130.00, for a total transaction of $330,850.00. The disclosure for this sale can be found here. 3.04% of the stock is currently owned by corporate insiders.
Several hedge funds have recently added to or reduced their stakes in ATHN. Advisor Group Inc. acquired a new stake in athenahealth during the second quarter worth approximately $118,000. FineMark National Bank & Trust raised its stake in athenahealth by 4.5% in the second quarter. FineMark National Bank & Trust now owns 944 shares of the company’s stock worth $130,000 after buying an additional 41 shares in the last quarter. KBC Group NV purchased a new stake in athenahealth during the second quarter worth about $135,000. Societe Generale purchased a new stake in athenahealth during the second quarter worth about $176,000. Finally, SG Americas Securities LLC raised its stake in athenahealth by 27.7% in the second quarter. SG Americas Securities LLC now owns 1,277 shares of the company’s stock worth $176,000 after buying an additional 277 shares in the last quarter.
athenahealth, Inc is a provider of cloud-based services and mobile applications for medical groups and health systems. The Company delivers cloud-based services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, care coordination, order transmission, population health management, and clinical decision support.
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.